ClinicalTrials.gg
RecruitingNCT06631872STTARRSUpdated Jun 10, 2026

Implementing Surgery School Prehabilitation Using Telehealth

An interventional study of Tele-prehabilitation education session: Surgery School and Individualised Inspiratory Muscle Training and Walking Program in Adults Waiting to Undergo Lung Cancer or Major Abdominal, Open or Video Assisted Cancer Surgery, sponsored by University of Melbourne. Recruiting at 9 sites in Australia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-10.

Sponsored by University of Melbourne · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Jan 2025; still recruiting 1 year 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
515
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 153 studies in Lung Neoplasms with a site in Australia — 51 open to participants now, 74 under way, 25 of them phase 3. Lung Neoplasms · Australia.

Planned enrollment
36th of 140
515 · median 215
Started
2025
with 16 others
No phase
13 of 153
7 open now
Primary completion
2027-07
later than 31 of 73 live
Registered
122nd of 153
by date

Among the 153 studies in Lung Neoplasms with a site in Australia, this one is the 36th largest by planned enrollment of the 140 interventional ones that give a count, is one of 17 that started in 2025, is one of 13 with no phase, reaches primary completion later than 31 of the 73 other live ones, and was the 122nd registered.

Lung Neoplasms

5,436 studies on the registry are indexed under Lung Neoplasms; 1,350 are open to participants now.

Browse Lung Neoplasms studies →

Open to participants now

51 of the 153 studies in Lung Neoplasms with a site in Australia are open now. Recruiting first, the newest first:

46 more — sign in →

All 51 open studies →

A study can be open while its sites in Australia have not opened yet or have stopped. Only those recruiting at a site in Australia →

Who these studies take

Of the 997 Lung Neoplasms studies recruiting now, 686 (69%) set no upper age limit and 143 (14%) stop at 75 or younger; 45 take children under 18; 143 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 153 studies in Lung Neoplasms with a site in Australia, or all of them as a file.
02

Study summary

The physiological challenge of major surgery has been likened to running a marathon. In both cases, preparation is critical. Yet, many patients undergo major surgery without understanding the potential consequences.

The STTARRS trial aims to test the effect of an education program delivered via telehealth in people preparing for lung or major abdominal cancer surgery , compared with usual care on the development of a respiratory complications after surgery.

The secondary aims will be to determine the effect of the online education program for people preparing for lung or major abdominal cancer surgery compared to usual care on the following outcomes; acute hospital length of stay, surgical recovery, physical function and activity, self-efficacy, behaviour change, symptoms, health-related quality of life, number of days alive and out of hospital and health service usage and survival.

This trial includes one sub-study. The sub-study will recruit eligible people preparing for lung cancer surgery. In the sub-study, 35 participants will receive an individualised inspiratory muscle training and walking program delivered and monitored by telehealth in addition to the main STTARRS trial intervention before surgery.

03

Conditions studied

  • Adults Waiting to Undergo Lung Cancer or Major Abdominal, Open or Video Assisted Cancer Surgery

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Preparing for lung cancer (open or video assisted) or major abdominal cancer surgery (e.g. upper GI, hepatobiliary or colorectal, open or video assisted).
  • Provide consent
  • Have primary treating surgeon approval
  • Proficient in English to understand testing, video interventions as well as outcome assessments.

Exclusion criteria

Exclusion Criteria:

  • Concurrent, actively treated other or history of other malignancy treated within the past year.
  • Severe or unstable psychiatric, cognitive or substance abuse disorders, such that precludes or interferes with cooperation with trial requirements or current inpatients.
  • Current inpatients or incarcerated
  • Surgery date booked \<7 days from consent
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
515 participants (estimated)

Study arms

  • Experimental
    Tele-prehabilitation intervention (Intervention Group)

    The Teleprehabilitaiton intervention (also known as Surgery School) is a one-off group based education session delivered online. Video presentations of 7 key prehabilitation education areas will be facilitated by a live clinician facilitator who will introduce the educational content and answer any questions. All standardised video presentations during the session will be made available to participants through an online password-protected video repository hosted on a video platform after the session and will be available until their surgery.

    Behavioral: Tele-prehabilitation education session: Surgery School

  • Active comparator
    Usual care alone (Control Group)

    Participants allocated to the control group will receive usual care according to their health care team, which may consist of advice on smoking cessation, reduction of alcohol intake, nutritional counselling and medical optimisation in preoperative anaesthetic clinic visits. Participants will be asked to maintain their normal daily activities.

    Other: Usual Care

  • Experimental
    Sub-study: Tele-prehabilitation and inspiratory muscle training program

    Eligible participants awaiting lung cancer surgery that have been randomised into the intervention arm will be re-randomised to receive either the STTARRS (larger trial) intervention or the STTARRS intervention PLUS an individualised inspiratory muscle training and walking program delivered by a physiotherapist using telehealth in the lead up to their lung cancer surgery. The inspiratory muscle training program includes an inspiratory muscle training explanatory video and an individually prescribed dosage and resistance for inspiratory muscle training and walking program, delivered via telehealth.

    Behavioral: Tele-prehabilitation education session: Surgery School · Behavioral: Individualised Inspiratory Muscle Training and Walking Program

  • Active comparator
    Sub-study: Tele-prehabilitation intervention

    The Teleprehabilitaiton intervention (also known as Surgery School) is a one-off group based education session delivered online. Video presentations of 7 key prehabilitation education areas will be facilitated by a live clinician facilitator who will introduce the educational content and answer any questions. All standardised video presentations during the session will be made available to participants through an online password-protected video repository hosted on a video platform after the session and will be available until their surgery.

    Behavioral: Tele-prehabilitation education session: Surgery School

Interventions

  • BehavioralTele-prehabilitation education session: Surgery School

    Online telehealth education program using videos and a live clinician facilitator

  • BehavioralIndividualised Inspiratory Muscle Training and Walking Program

    An individualised inspiratory muscle training and walking program delivered by a Physiotherapist using telehealth.

  • OtherUsual Care

    Usual care alone. Usual care will be reviewed every four months during the trial and site leads will be asked to provide information about any changes to usual hospital and medical care at their site.

06

What researchers measure

Primary outcomes

  1. Post operative Pulmonary Complication (PPC)

    Post operative pulmonary complications (PPC) will be assessed using the Melbourne Group Score (MGS). The MGS is an eight-item checklist. Minimum score 0, Maximum score 8. Participants are identifying as having a PPC if they score four or more in a 24-hour period.

    Time frame: Daily for up to 7 days post operatively or until hospital discharge.

Secondary outcomes

  1. Diagnosis of pneumonia

    Diagnosis of pneumonia (Y/N) classified according the centre for disease control definition.

    Time frame: Daily up to postoperative day 7 or until hospital discharge

  2. Postoperative complications

    Complications after surgery will be defined as any deviation from the normal postoperative course and classified according to the Clavien-Dindo classification. from Grade I through GradeV. Higher classifications indicating complications that require more complex interventions.

    Time frame: Postoperative day 3,5,10 unless discharge prior and 30 days post operative.

  3. Number of days alive and out of hospital

    DAoH-30, DAoH-180, DAoH-365 (days alive and out of hospital 30, 180, 365 days post operatively): a patient centric metric and composite outcome that integrates several clinically important outcomes: hospital length of stay, re-admission or discharge to a destination other than origin (usually home) as well as survival. Higher numbers indicate a greater time alive and out of hospital post operatively.

    Time frame: 30 days, 6 months and 12 months post operative

  4. Maximal Inspiratory Pressure (MIP)

    Maximal Inspiratory Pressure (cm H2O) will be assessed using a small handheld device using 3 tests of inspiratory muscle strength recording the highest value. Undertaken at centres participating in the sub study.

    Time frame: Baseline and preoperatively at centres participating in the inspiratory muscle training sub study

  5. Physical activity levels - subjective

    Physical activity levels will be documented subjectively using the International Physical Activity Questionnaire - Short Form (IPAQ-SF). The IPAQ-SF is a questionnaire used internationally to obtain comparable estimates of physical activity. The questionnaire comprises seven questions related to physical activity at different levels of intensity and sitting time. Results will be reported in categories (low activity levels, moderate activity levels or high activity levels) and a continuous variable (MET minutes a week). Higher METs or categories indicate higher levels of physical activity.

    Time frame: Baseline, Preoperatively, 30 days post operative

  6. Physical activity levels - objective

    Physical activity levels will be collected objectively using wearable monitors, such as fitbits for three days at baseline, three days after the intervention and at 30 days postoperatively. Physical activity variables will include the total number of daily steps, daily minutes of moderate to vigorous physical activity (MVPA), peak 1-minute cadence (the highest single minute of steps recorded), and peak 30-minute cadence (the average steps/min for the highest non-consecutive 30 minutes in a day). A minimum of 8 hours over 3 days is considered valid wear time for physical activity data. Values are described using mean +/- standard deviation and mean difference (MD) with 95% confidence intervals (95% CI).

    Time frame: Baseline, Preoperatively, 30 days post operative

  7. Video and Surgery School Session Attendance (Intervention group only)

    Attendance at Surgery School session, length of time attended the Surgery School session and number of questions asked during Surgery School session.

    Time frame: Preoperative timepoint

  8. Access to video outside the Surgery School Session (Intervention group only)

    The number of times the videos are accessed outside of the Surgery School session, site, day of week, time of day will be collected. Number of questions asked during Surgery School session.

    Time frame: Preoperative timepoint

  9. Symptoms: electronic Edmonton Symptom Assessment System-revised ((e)ESAS-r)

    The electronic Edmonton Symptom Assessment System-revised ((e)ESAS-r) is a 10-item assessment tool for self-reporting symptom intensity via electronic platforms for digital use. The (e)ESAS-r allows participants to rate the severity of common symptoms as well as the opportunity to rate 'other problems' as nominated by the participant on a scale from 0 to 10 with higher score indicating higher severity of symptoms

    Time frame: Baseline (and repeated every 4 weeks for participants having treatment before surgery), Preoperative, Postoperative: 30 days.

  10. Behaviour Change

    Behaviour change will be measured using a bespoke questionnaire: STTARRS behaviour change questionnaire (SBCQ) developed to assess patient action related to information (a) contained within the videos and surgery school session (intervention group) and (b) for usual care participants information provided to them through educational materials. This patient reported experience measure will measure responses to questions on a 5-point Likert scale (strongly disagree to strongly agree). Results will be presented descriptively. Higher responses on the likert scales indicates a higher agreement.

    Time frame: Preoperative timepoint, at hospital discharge (+3 days)

  11. Self-efficacy: Patient Activation Measure

    Patient Activation Measure (PAM) is a questionnaire assessing three key domains: knowledge, skills, confidence to understand self-management ability. The PAM is a 13-item survey scored on a 100 point scale, with 4 activation levels validated for across time measures and used world-wide. PAM Levels 1 and 2 indicate lower patient activation, while PAM levels 3 and 4 indicate higher patient activation.

    Time frame: Baseline, preoperative timepoint, 30 days and 6 months postoperative.

  12. Treatment Burden: Multimorbidity Treatment Burden Questionnaire (MTBQ)

    Multimorbidity Treatment Burden Questionnaire (MTBQ) is a 13 item questionnaire that assesses the perception of the effort required to self-manage their medical conditions and the impact that this has on their wellbeing. The MTBQ has demonstrated good content and construct validity, reliability and responsiveness. The MTBQ is scored from 0-100 with higher scores indicating higher treatment burden which fall into four categories: no burden (score 0), low burden (score \<10), medium burden (10-22) and high burden (\>=22).

    Time frame: Baseline, preoperative timepoint, 30 days postoperative

  13. Viewer perceptions of the intervention (intervention group only)

    Viewer perceptions of the intervention including perceived personal relevance will be assessed using a previously published questionnaire. The questionnaire includes questions on four domains: helpfulness, believability, novelty, and relevance of information. A total of 7 questions all rate on 0-6 Likert scales from strongly disagree to strongly agree, with higher score indicating stronger agreement and an additional yes/no question asked regarding whether participants intend to change any behaviours.

    Time frame: Preoperative timepoint

  14. Feasibility of the teleprehabilitation program: Proportion of eligible patients participating

    Portion of eligible patients participating will be collected and reported as a percentage of all patients eligible for the trial.

    Time frame: Time Frame: Through study recruitment, up to 2.5 years

  15. Feasibility of the teleprehabilitation program: Representativeness

    Representativeness relative to a wider group of eligible patients presented descriptively

    Time frame: Time Frame: Through study recruitment, up to 2.5 years

  16. Feasibility of the teleprehabilitation program: Referral rates

    Actual teleprehabilitation referral rates as a % of total eligible to be referred

    Time frame: Time Frame: Through study recruitment, up to 2.5 years

  17. Feasibility of the teleprehabilitation program: reasons for declining

    Reasons for declining will be reported descriptively.

    Time frame: Time Frame: Through study recruitment, up to 2.5 years

  18. Acceptability

    Participants will be asked to complete a survey regarding trial acceptability. The survey questions will be based upon the Theoretical Framework of Acceptability. The framework comprises seven domains designed to assess acceptability elements: perceived effectiveness, self-efficacy, affective attitude, ethicality burden, intervention coherence and opportunity costs.

    Time frame: Preoperative timepoint, at hospital discharge (+3 days), 30 days post operative

  19. Fidelity (treatment delivery): Tele-prehabilitation education session duration

    Treatment delivery: using duration of education session provided (minutes).

    Time frame: Through study data collection, up to 2.5 years

  20. Fidelity (treatment delivery): Number of videos accessed

    Treatment delivery: total number of videos accessed, presented descriptively and also by video title.

    Time frame: Through study data collection, up to 2.5 years

  21. Fidelity (treatment delivery): Number of video views

    Treatment delivery: using number of videos viewed, results presented descriptively .

    Time frame: Through study data collection, up to 2.5 years

  22. Fidelity (treatment delivery): Telehealth implementation process concordance with implementation protocol.

    Treatment delivery (centre level): using process concordance with implementation protocol.

    Time frame: Through study data collection, up to 2.5 years

  23. Fidelity (treatment delivery): viewing time

    Treatment delivery: using the time of participant viewing (minutes).

    Time frame: Through study data collection, up to 2.5 years

  24. Fidelity (treatment receipt): participant attendance at telehealth meeting

    Treatment receipt: % of participants who attend a session once booked in

    Time frame: Through study data collection, up to 2.5 years

  25. Fidelity (treatment receipt): number of questions

    Treatment receipt: the number of questions per session will be recorded.

    Time frame: Through study data collection, up to 2.5 years

  26. Fidelity (treatment receipt): participant retention at follow up

    Treatment receipt: the number of participants attending follow up will be recorded (% of total participants).

    Time frame: Through study data collection, up to 2.5 years

  27. Participant satisfaction: Australian Hospital Experience Question Set (AHPEQS)

    The Australian Hospital Patient Experience Question Set (AHPEQS) is a 12-item questionnaire (ten core items and two sub-items) used to measure patient satisfaction with recent treatment. Questions are measured on responses from always to never or didn't apply. Results will be reported descriptively with positive responses indicating greater satisfaction with recent treatment.

    Time frame: 30 days post operative

  28. Health related quality of life: EORTC QLQ-C30

    European Organisation for the Research and Treatment of Cancer (EORTC QLQ- C30) core questionnaire is a measure composed of five multi-item domains (physical, role, emotional, cognitive function and social functioning). All of the scales and single-item measures range in score from 0 to 100. A high scale score represents a higher response level. A high score for a functional scale represents a high/healthy level of functioning. A high score for the global health status / quality of life represents a high quality of life but a high score for a symptom scale / item represents a high level of symptomatology / problems. The EORTC QLQ-C30 Summary score will also be reported and is calculated from the mean of 13 of the 15 QLQ-C30 scale, with higher score indicating a higher quality of life. This tool has established validity and reliability in cancer.

    Time frame: Baseline, Preoperative, 30 days, 6 months and 12 months post operative

  29. Postoperative Quality of Recovery: Postoperative Quality of Recovery Score (PostopQRS)

    The Postoperative Quality of Recovery Score (PostopQRS) is a multidimensional recovery assessment tool that is a verbal questionnaire. It has proven patient user acceptance and has been validated to be performed either face to face or over the telephone. The core domains include physiologic, nociceptive, functional, cognitive and emotional recovery and satisfaction with care, that is designed for use over multiple timepoints. The PostopQRS provides objective assessment of post-operative recovery, analysing the core domains of recovery, namely physiologic, nociceptive, functional, cognitive and emotional recovery compared to a unique individual preoperative baseline score. Recovery is then scored for each domain, and patients must recover in all tests within the domain to be scored as recovered. "All domains" recovery implies recovery in all of the five recovery domains.

    Time frame: Preoperative timepoint, 3 days and 6 days postoperatively (if not discharged prior), 30 days and 6 months postoperative

  30. Length of hospital stay

    Length of hospital stay will be documented from the medical records by a blinded assessor at each centre.

    Time frame: at hospital discharge

  31. Health service use and costs

    Captured in following ways: (i) hospital services and the use of health care services outside of hospital. (ii) Patients will be surveyed on their use of health services outside the hospital at 6 and 12 months postop follow-up using a questionnaire. (iii) Cost of program delivery

    Time frame: at hospital discharge, 30 days, 6 and 12 months post operative

  32. Exploratory Outcomes

    Teleprehabilitation is an intervention suitable for patients of low to moderately high perioperative risk levels, however subgroup analyses based on risk provide the opportunity to explore if teleprehabilitation offers additional benefits to patients of increasing risk level. Surgical procedure: Differences in PPC rates between the two surgical groups (abdominal and lung) and between those receiving or not receiving neo-adjuvant therapy before abdominal cancer surgery will be explored.

    Time frame: through study completion, up to 3 years

Other outcomes

  1. Sex

    After consent, participants' demographic data will be extracted from their medical record. Sex will be recorded as a categorical variable with categories: female, male, other.

    Time frame: Baseline

  2. Date of birth

    After consent, participants' demographic data will be extracted from their medical record, including date of birth (years).

    Time frame: Baseline

  3. Height

    After consent, participants' demographic data will be extracted from their medical record, including height (cm).

    Time frame: Baseline

  4. Weight

    After consent, participants' demographic data will be extracted from their medical record, including weight (kg).

    Time frame: Baseline

  5. Primary language spoken

    After consent, participants' demographic data will be extracted from their medical record, including primary language spoken (name of).

    Time frame: Baseline

  6. Proposed surgery

    After consent, participants' clinical data will be extracted from their medical record, including proposed surgery (category of abdominal cancer or lung cancer surgery) and description of surgery.

    Time frame: Baseline

  7. Medical history

    After consent, participants' clinical data will be extracted from their medical record, including medical conditions.

    Time frame: Baseline

  8. Social history: live alone

    After consent, participants' social data will be extracted from their medical record, including living situation, living alone (yes/no).

    Time frame: Baseline

  9. Social history: partner

    After consent, participants' social data will be extracted from their medical record, including living situation, if they have a partner (yes/no).

    Time frame: Baseline

  10. Work status

    After consent, participants' demographic data will be extracted from their medical record, including work status.

    Time frame: Baseline

  11. Postcode

    After consent, participants' demographic data will be extracted from their medical record, including postcode (zip code).

    Time frame: Baseline

  12. American Society of Anaesthesiologists (ASA) score

    The American Society of Anaesthesiologists (ASA) score is a longstanding score that includes a subjective assessment of a patient's overall health according to five classes; (i) Patient is a completely healthy fit patient, (ii) Patient has mild systemic disease, (iii) Patient has severe systematic disease that is not incapacitating, (iii) Patient has severe systemic disease that is not incapacitating, (iv) Patient has incapacitating disease that is a constant threat to life or (v) A moribund patient who is not expected to live 24 hours with or without surgery. A higher category indicates higher risk.

    Time frame: Baseline

  13. Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) score

    The Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) score is a valid tool for determining a patient's risk score for developing postoperative pulmonary complications. A higher score indicates higher risk of postoperative pulmonary complications and is classified as: low risk \<26, intermediate risk: 26-44, and high risk : \>=45.

    Time frame: Baseline

  14. Frailty

    Frailty is a multidimensional geriatric syndrome characterised by a decline of physical and cognitive reserves that leads to increased vulnerability. It will be measured using the modified Reported Edmonton Frail Scale. The scale is a questionnaire with 13 items with a total score of 0 to 18. Scores are converted into the following categories: (0-5) not frail, (6-7) apparently vulnerable, (8-9) mild frailty, (10-11) moderate frailty and (12-18) severe frailty.

    Time frame: Baseline

  15. Survival

    Patients will be followed to assess if they are alive at 12 months post operatively.

    Time frame: 12 months post operative

  16. Surgical and anaesthetic information

    Intraoperative details of surgical procedure, type of anaesthesia and reversal agent

    Time frame: at hospital discharge

07

Study locations

8 of 9 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2025 (actual). Primary completion is estimated for Jul 2027, 30 months after the start.

Of 871 non-industry interventional studies with no phase under Lung Neoplasms, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 69. This study's planned 30 months is below that.

Counting every sponsor, half of 922 studies reached it within 34 months; a quarter within 15 and three quarters within 67.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 15, 2024
First posted
Oct 8, 2024
StartActual
Jan 22, 2025
Primary completionEst.
Jul 2027
CompletionEst.
Jul 2028
Last update
Jun 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06631872
Lead sponsor
University of Melbourne
Collaborators
Peter MacCallum Cancer Centre, Australia
Responsible party
Sponsor
First posted
Oct 8, 2024
Start date
Jan 22, 2025
Primary completion
Jul 2027 (estimated)
Completion
Jul 2028 (estimated)
Last update
Jun 10, 2026

Study contacts

Linda Denehy, B AppSc (Physio), PhD
Contact
l.denehy@unimelb.edu.au
+61 3 8344 6428
Jamie Waterland, B Physio(Hons), PhD
Contact
jamie.waterland@unimelb.edu.au
+61 3 8559 8223
Linda Denehy, B AppSc (Physio), PhD
principal investigator · University of Melbourne

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion